To test whether this NCR-based chimeric receptor could trigger the upregulation of T-cell activation markers, N1/28z- or NGFR- transduced T-cells were co-cultured overnight with different tumor lines and analyzed for surface expression of activation markers (CD25 and CD69). Here, CD69 is linked to neoplasm.